MedTrace Logo

Thrombospondin-1 and Pigmented Epithelium Derived Factor Levels in Patients With Diabetes Mellitus.

NCT01809093 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2017-02-23

No results posted yet for this study

Summary

You are being asked to be in a research study to determine blood levels and vitreous levels of compounds called thrombospondin 1 (TSP1) and pigment epithelium derived factor (PEDF). These compounds exists naturally in your body.

Conditions

Interventions

BIOLOGICAL

Blood draw

3-4 tablespoons of blood will be drawn, one time.

Sponsors & Collaborators

  • MidAtlantic Retina

    lead OTHER

Principal Investigators

  • Marc Spirn, M.D.

Eligibility

Min Age
18 Minutes
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-03-31
Primary Completion
2014-03-31
Completion
2014-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01809093 on ClinicalTrials.gov